Peculiarities of epithelial-mesenchymal transition in endometrial carcinomas

Authors

  • I. Nesina R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology

DOI:

https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-4.16982

Keywords:

endometrioid endometrial carcinoma, epithelial-mesenchymal transition, Snail, transcription factors, Twist, ZEB

Abstract

Summary. Epithelial-mesenchymal transition is an important component of tumor progression, due to which the cells of malignant neoplasms acquire invasive and migratory properties. Analysis of the literature and our own data show that the activation of proteins involved in epithelial-mesenchymal transition crucially affects the progression of endometrioid carcinoma of the endometrium and the significant variability of their expression could determine the clinical and morphological heterogeneity of this cancer. The most aggressive endometrioid carcinomas of the endometrium are characterized by a hybrid epithelial-mesenchymal phenotype, which is often associated with a collective type of invasion of endometrial tumor cells into the myometrium.

References

Fedorenko ZP, Mikhailovich YU, Gulak LO, et al. Cancer in Ukraine, 2019-2020. Morbidity, mortality, indicators of oncology service activity. Bul Nat Registry of Ukraine 2021; 22: 82 p. http://www.ncru.inf.ua

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics 2021. CA. Cancer J Clin 2021; 71: 7–33. https://doi.org/10.3322/caac.21654

Nyen TV, Moiola CP, Colas E, et al. Modeling endometrial cancer: past, present, and future. Іnt J Mol Sci 2018; 19: 2348. https://doi.org/10.3390/ijms19082348

Francou A, Anderson KV. The epithelial-to-mesenchymal transition in development and cancer. Annu Rev Cancer Biol 2020; 4: 197–220. https://doi.org/10.1146/annurev-cancerbio-030518-055425

Qin J-H, Wang L, Li Q-L, et al. Epithelial-mesenchymal transition as strategic microenvironment mimicry for cancer cell survival and іmmune escape? Genes Dis 2017; 4: 16–8. https://doi.org/10.1016/j.gendis.2016.10.001

Jolly MK, Ware KE, Gilja S, et al. EMT and MET: Ne¬cessary or permissive for metastasis? Mol Oncol 2017; 11: 755–69. https://doi.org/10.1002/1878-0261.12083

Williams ED, Gao D, Redfern A, Thompson EW. Controversies around epithelial-mesenchymal plasticity in cancer metastasis. Nat Rev Cancer 2019; 19: 716–32. https://doi.org/10.1038/s41568-019-0213-x

Bhatia S, Wang P, Toh A, Thompson EW. New insights into the role of phenotypic plasticity and EMT in driving cancer progression. Front Mol Biosci 2020; 7: 71.https://doi.org/10.3389/fmolb.2020.00071

Chaffer CL, Juan BPS, Lim E, Weinberg RA. EMT, cell plasticity and metastasis. Cancer Metastasis Rev 2016; 35: 645–54. https://doi.org/10.1007/s10555-016-9648-7

Liao T-T, Yang M-H. Hybrid epithelial/mesenchymal state in cancer metastasis: clinical significance and regulatory mechanisms. Cells 2020; 9: 623. https://doi.org/10.3390/cell9030623

Tolibova GKh, Tral TG, Ailamazyan EK, et al. Molecular mechanisms of cyclic transformation of the endometrium. J Obstetrics Women’s Dis 2019; 68: 5–12:https://doi.org/10.17816/JOWD6815-12 (in Russian)

Sanderson PA, Critchley HO, Williams AR, et al. New concepts for an old problem: The diagnosis of endometrial hyperplasia. Hum Reprod Update 2017; 23: 232–54. https://doi.org/10.1093/humupd/dmw042

Chiu H-C, Li C-J, Yiang G-T, et al. Epithelial to mesenchymal transition and cell biology of molecular regulation in endometrial carcinogenesis. J Clin Med 2019; 8: 439. https://doi.org/10.3390/jcm8040439

Buchynska LG, Borykun TV, Iurchenko NP, et al. Еxpression of microRNA in tumor cells of endmetrioid carcinoma of endometrium. Exp Oncol 2020; 42: 289–94. https://doi.org/10.32471/exp-oncology.2312-8852

Škovierová H, Okajčeková T, Strnádel J, et al. Molecular regulation of epithelial to mesenchymal transition in tumorigenesis (Review). Int J Mol Med 2018; 41: 1187–200. https://doi.org/10.3892/ijmm.2017.3320

Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial–mesenchymal transition. Nat Rev Mol Cell Biol 2014; 15: 178–96. https://doi.org/10.1038/nrm3758

Ribatti D, Tamma R, Annese T. Epithelial-mesenchymal transition in cancer: a historical overview. Transl Oncol 2020; 13: 100773. https://doi.org/10.1016/j.tranon.2020.100773

Kang E, Seo J, Yoon H, Cho S. The post-translational regulation of epithelial–mesenchymal transition-inducing transcription factors in cancer metastasis. Int J Mol Sci 2021: 22: 3591.https://doi.org/10.3390/ijms22073591

Huang L, Jin Y, Feng S, et al. Role of Wnt/β-catenin, Wnt/c-Jun N-terminal kinase and Wnt/Ca2+ pathways in cisplatin-induced chemoresistance in ovarian cancer. Exp Ther Med 2016; 12: 3851–8. https://doi.org/10.3892/etm.2016.3885

Makker A, Goel MM. Tumor progression, metastasis, and modulators of epithelial–mesenchymal transition endometrioid endometrial carcinoma: an update. Endocr Relat Cancer 2016; 23: 85–111. https://doi.org/10.1530/ERC-15-0218

McMellen A, Woodruff ER, Corr BR, et al. Wnt signaling in gynecologic malignancies. J Mol Sci 2020; 21: 4272. https://doi.org/10.3390/ijms21124272

Goad J, Ko YA, Kumar M, et al. Oestrogen fuels the growth of endometrial hyperplastic lesions initiated by overactive Wnt/β-catenin signalling. Carcinogenesis 2018; 39: 1105–16. https://doi.org/10.1093/carcin/bgy079

Kasoha M, Dernektsi C, Seibold A, et al. Crosstalk of estrogen receptors and Wnt/β-catenin signaling in endometrial cancer. Cancer Res Clin Oncol 2020; 146: 315–27. https://doi.org/10.1007/s00432-019-03114-8

Wang Y, Hanifi-Moghaddam P, Hanekamp EE, et al. Progesterone inhibition of Wnt/β-catenin signaling in normal endometrium and endometrial cancer. Clin Cancer Res 2009; 15: 5784–93. https://doi.org/10.1158/1078-0432.CCR-09-0814

Ahmadi A, Najafi M, Farhood B, Mortezaee K. Transforming growth factor β signalling: Tumorigenesis and targeting for cancer therapy. J Cell Physiol 2019; 234: 12173–87. https://doi.org/10.1002/jcp.27955

Derynck R, Muthusamy BP, Saeteurn KY. Signaling pathway cooperation in TGF-β-induced epithelial–mesenchymal transition. Curr Оpin Сell Вiol 2014; 31: 56–66. https://doi.org/10.1016/j.ceb.2014.09.001

Bokhari AA, Lee LR, Raboteau D, et al. Progeste¬rone inhibits endometrial cancer invasiveness by inhibiting the TGF-β pathway. Cancer Prev Res 2014; 7: 1045–55. https://doi.org/10.1158/1940-6207.CAPR-14-0054

Paucarmayta A, Taitz H, Casablanca Y, et al. TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types. Transl Cancer Res 2019; 8: 1423–37. doi: org/10.21037/tcr.2019.07.36

Fatima I, Barman S, Rai R, et al. Targeting Wnt signaling in endometrial cancer. Cancers (Basel) 2021; 13: 2351.https://doi.org/10.3390/cancers13102351

Kurnit KC, Draisey A, Kazen RC, et al. Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to promoter in endometrial cancer. Cancer Let 2021; 505: 75–86. https://doi.org/10.1016/j.canlet.2021.01.030

Sahoo SS, Zhang XD, Hondermarck H, Tanwar PS. The emerging role of the microenvironment in endometrial cancer, Cancers (Basel) 2018; 10: 408. https://doi.org/10.3390/cancers10110408

Subramaniam KS, Omar IS, Kwong SC, et al. Cancer associated fibroblasts promote endometrial cancer growth via activation of interleukin-6/STAT-3/c-Myc pathway. Am J Cancer Res 2016; 6: 200–13: http://www.ajcr.us/ISSN:2156-6976/ajcr0021359

Chen Y, Song Y, Du W, et al. Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci 2019; 26: 78. https://doi.org/10.1186/s12929-019-0568-z

Li M, Xin X, Wu T, et al. Stromal cells of endometrial carcinoma promotes proliferation of epithelial cells through the HGF/c-Met/Akt signaling pathway. Tumour Biol 2015; 36: 6239–48. https://doi.org/10.1007/s13277-015-3309-2

Buchynska LG, Movchan OM, Iurchenko NP. Expression of chemokine receptor CXCR4 in tumor cells and content of CXCL12+-fibroblasts in endometrioid carcinoma of endometrium. Exp Oncol 2021; 43: 135–41. https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16240

Yoriki K, Mori T, Kokabu T, et al. Estrogen-related receptor alpha induces epithelial-mesenchymal transition through cancer-stromal interactions in endometrial cancer. Sci Rep 2019; 9: 6697.https://doi.org/10.1038/s41598-019-43261-z

Chen H-Y, Chiang Y-F, Huang J-S, et al. Isoliquiritigenin reverses epithelial-mesenchymal transition through modulation of the TGF-β/Smad signaling pathway in endometrial cancer. Cancers (Basel) 2021; 13: 1236.https://doi.org/10.3390/cancers13061236

Romeo E, Caserta CA, Rumio C, Marcucci F. The vicious cross-talk between tumor cells with an EMT phenotype and cells of the immune system. Cells 2019; 8: 460. https://doi.org/10.3390/cells8050460

Dhanasekaran R, Baylot V, Kim M, et al. MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity. Cancer Biol 2020; 14: 202. https://doi.org/10.7554/eLife.50731

Nesina I, Iurchenko N, Nespriadko S, Buchynska L. Twist expression and content of tumour-associated macrophages in endometrial carcinoma. Oncol Clin Pract 2021; 17: 139–47. https://doi.org/10.5603/OCP.2021.0026

Abba ML, Patil N, Leupold JH, Allgayer H. MicroRNA regulation of epithelial to mesenchymal transition. J Clin Med 2016; 5: 8. https://doi.org/10.3390/jcm5010008

Zaravinos A. The regulatory role of microRNAs in EMT and cancer. J Оncol 2015; 2015: 865816. https://doi.org/10.1155/2015/865816

Deng J, Wang W, Yu G, Mа X. MicroRNA-195 inhibits epithelial-mesenchymal transition by targeting G protein-coupled estrogen receptor 1 in endometrial carcinoma. Mol Med Reports 2019; 20: 4023-32. https://doi.org/10.3892/mmr.2019.10652

Gugnoni M, Ciarrocchi A. Long noncoding RNA and epithelial mesenchymal transition in cancer. J Mol Sci 2019; 20: 1924. https://doi.org/10.3390/ijms20081924

Landeros N, Santoro PM, Carrasco-Avino G, Corvalan AH. Competing endogenous RNA networks in the epithelial to mesenchymal transition in diffuse-type of gastric cancer. Cancers (Basel) 2020; 12: 2741. https://doi.org/10.3390/cancers12102741

Liu W, Zhang B, Xu N, et al. miR-326 regulates EMT and metastasis of endometrial cancer through targeting TWIST1. Eur Rev Med Pharm Sci 2017; 21: 3787–93.

Buchynska LG, Borykun TV, Iurchenko NP, et al. Еxpression of microRNA in tumor cells of endmetrioid carcinoma of endometrium. Exp Oncol 2020; 42: 289–94. https://doi.org/10.32471/exp-oncology.2312-8852

Donkers H, Bekkers R, Galaal K. Diagnostic value of microRNA panel in endometrial cancer: A systematic review. Oncotarget 2020; 11: 2010–23. https://doi.org/10.18632/oncotarget.27601

Piergentili R, Zaami S, Cavaliere AF, et al. Non-coding RNAs as prognostic markers for endometrial cancer. Int J Mol Sci 2021; 22: 3151.https://doi.org/10.3390/ijms2206315

Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Mol Cancer 2016; 15: 18. HTTPS://DOI.ORG/10.1186/s12943-016-0502

Dave N, Guaita-Esteruelas S, Gutarra S, et al Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition. J Biol Chem 2011; 286: 12024–32. https://doi.org/10.1074/jbc.M110.168625

Xu R, Won J-Y, Kim C-H, et al. Roles of the рhosphorylation of transcriptional factors in epithelial-mesenchymal transition. J Oncol 2019; ID: 5810465:https://doi.org/10.1155/2019/5810465

Lin Y, Wang Y, Shi Q, et al. Stabilization of the transcription factors Slug and Twist by the deubiquitinase Dub3 is a key requirement for tumor metastasis. Oncotarget 2017; 8: 75127–40: https://doi.org/10.18632/oncotarget.20561

Sreekumar R, Al-Saihati H, Emaduddin M, et al. The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer. Mol Oncol 2021; 15: 2065–83. https://doi.org/10.1002/1878-0261.12965

Tanaka Y, Terai Y, Kawaguchi H, et al. Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer. Cancer Biol Ther 2013; 14: 13–9. https://doi.org/10.4161/cbt.22625

Abouhashem NS, Ibrahim DA, Mohamed AM. Prognostic implications of epithelial to mesenchymal transition proteins (E-cadherin, Snail) and hypoxia inducible factor endometrioid endometrial carcinoma. Ann Diagn Pathol 2016; 22: 1–11. https://doi.org/10.1016/j.anndiagpath.2016.01.004

Xie X, Zheng X, Wang J, Chen L. Clinical significance of Twist, E-cadherin, and N-cadherin protein expression in endometrioid adenocarcinoma. J Can Res Ther 2017; 13: 817–22.https://doi.org/10.1155/2019/5810465

Feng Z, Gan H, Cai Z, et al. Aberrant expression of hypoxia-inducible factor 1α, TWIST and E-cadherin is associated with aggressive tumor phenotypes in endometrioid endometrial carcinoma. Jpn J Clin Oncol 2013; 43: 396–403. https://doi.org/10.1093/jjco/hys237

Senol S, Sayar I, Ceyran AB, et al. Stromal clues in endometrial carcinoma: loss of expression of β-catenin, epithelial-mesenchymal transition regulators, and estrogen-progesterone receptor. Int J Gynecol Pathol 2016; 35: 238–48. doi:10:1097/PGP:0000000000000233

Sadłecki P, Jóźwicki J, Antosik P, Walentowicz-Sadłecka M. Expression of selected epithelial-mesenchymal transition transcription factors in endometrial cancer. Biomed Res Intern 2020; 2020: 4584250.https://doi.org/10.1155/2020/4584250

Krögera C, Afeyana A, Mraz J, et al. Acquisition of a hybrid E/M state is essential fortumorigenicity of basal breast cancer cells. PNAS 2019; 116: 7353–62. doi/10.1073/pnas.1907473116

Roberta R-M, Emina B, Danijela V-M, et al. The immunohistochemical pattern of epithelial-mesenchymal transition markers in endometrial carcinoma. Appl IHC Mol Morph 2020; 28: 339–46. https://doi.org/10.1097/PAI.0000000000000754

Buchynska LG, Naleskina LА, Nesina IP. Morphological characteristics and expression features of adhesion markers in cells of low differentiated endometrial carcinoma. Exp Oncol 2019; 41: 335–41. https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-4.13965

Wilson MR, Reske JJ, Holladay J, et al. ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion. Nat Commun 2019; 10: 3554.https://doi.org/10.1038/s41467-019-11403-6

Downloads

Published

26.05.2023

How to Cite

Nesina, I. (2023). Peculiarities of epithelial-mesenchymal transition in endometrial carcinomas. Experimental Oncology, 43(4), 282–289. https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-4.16982